A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer. Researchers discuss the findings.

Suleika Jaouad’s new book provides a master class in personal writing. Here’s why it’s a worthwhile habit — for everyone, not ...

The Stand Up To Cancer Walkies challenge, supported by The Kennel Club, asks pet parents and their canine companions to clock up the distance - or whatever represents a personal challenge - over the ...

Women who consume at least one sugar-sweetened beverage daily have a five times higher chance of developing oral cancer, which forms in the oral cavity. Oral cancer forms when cells on the lips or ...

Rep. Andy Barr possesses a political attribute so remarkable he hopes to parlay it into a seat in the U.S. Senate next year — ...

A new drug is showing promise in tackling treatment-resistant ovarian cancer. Relacorilant ... Relacorilant, which is administered as an oral pill, was reportedly "well-tolerated" by patients ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., April 24, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that new ...

The Head and Neck Cancer Foundation will host nearly 30 free screening events across the country during Head and Neck Cancer Awareness week April 14-18. The Lakeville screening will take ...

The precise use of immunotherapy agents in locally advanced head and neck squamous cell carcinoma has not been clearly ...